Bank Julius Baer & Co. Ltd, Zurich Novo Cure LTD Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$60.15 - $84.52 $12,030 - $16,904	-200 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$75.08 - $121.99 $3,754 - $6,099	50 Added 33.33%	200 $15,000
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $116 - $194	1 Added 0.67%	150 $17,000
Q2 2021 Jul 23, 2021	SELL	$130.4 - $225.58 $130 - $225	-1 Reduced 0.67%	149 $33,000
Q1 2021 May 10, 2021	BUY	$124.11 - $190.17 $5,709 - $8,747	46 Added 44.23%	150 $20,000
Q1 2020 May 13, 2020	BUY	$57.05 - $95.75 $5,933 - $9,958	104 New	104 $7,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.